-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, BgG/jW/r44pjV4mma1NrLthwkeyVi7zsOfr+luRh/zjU0zLmrN6DvqnuxiOS65EG D/o7IkAzxxsRl79IX/cQtQ== 0001225208-09-000752.txt : 20090106 0001225208-09-000752.hdr.sgml : 20090106 20090106161441 ACCESSION NUMBER: 0001225208-09-000752 CONFORMED SUBMISSION TYPE: 4/A PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20081209 FILED AS OF DATE: 20090106 DATE AS OF CHANGE: 20090106 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE BOSTON SCIENTIFIC PL CITY: NATICK STATE: MA ZIP: 01760-1537 BUSINESS PHONE: 5086508000 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: NICHOLAS PETER M CENTRAL INDEX KEY: 0000901458 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-11083 FILM NUMBER: 09510148 BUSINESS ADDRESS: STREET 1: C/O BOSTON SCIENTIFIC CORP STREET 2: ONE BOSTON SCIENTIFIC PLACE CITY: NATICK STATE: MA ZIP: 01760-1537 BUSINESS PHONE: 5086508567 MAIL ADDRESS: STREET 1: C/O BOSTON SCIENTIFIC CORPORATION STREET 2: ONE BOSTON SCIENTIFIC PLACE CITY: NATICK STATE: MA ZIP: 01760-1537 4/A 1 doc4a.xml X0303 4/A 2008-12-09 2008-12-11 0000885725 BOSTON SCIENTIFIC CORP BSX 0000901458 NICHOLAS PETER M ONE BOSTON SCIENTIFIC PLACE NATICK MA 01760-1537 1 Common Stock 2008-12-09 4 S 0 100000 7.358 D 19930032 I By Ltd. Partnership Common Stock 2008-12-10 4 S 0 100000 7.253 D 19830032 I By Ltd. Partnership Forward Sale Contract 0 2008-12-09 4 J 0 102722 0 A 2009-12-09 2009-12-09 Common Stock 102722 102722 I By Ltd. Partnership This form is being amended to correct the date originally inserted next to the signature line. The original filing indicates that the form was signed on 12/11/2009. The correct signature date is 12/11/2008. The original transactions are being reported in order to gain access to the SEC filing system. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 28, 2008. The weighted average sales price is reported as stock sales were aggregated for reporting purposes. The per share transaction price ranged from $7.50 to $7.17. The reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices. The weighted average sales price is reported as stock sales were aggregated for reporting purposes. The per share transaction price ranged from $7.43 to $7.13. The reporting person will provide, upon request from an appropriate party, the per share sales volumes and prices. On November 28, 2008, a family limited partnership of which the reporting person is a general and limited partner, Promerica L.P., entered into a Rule 10b5-1 trading plan with an unaffiliated commercial bank to execute a series of variable prepaid forward sale contracts. Under the contract reported on this form, Promerica will deliver to the bank up to 102,722 shares of the Issuer's common stock depending on market prices at maturity on December 9, 2009. If the market price per share at maturity is equal to or less than the floor price of $7.343 per share, Promerica will deliver 102,722 shares to the bank. If the market price per share at maturity is greater than the floor price, Promerica will deliver a fewer number of shares. In exchange, the bank is obligated to pay $614,157.73 to Promerica three business days after the date of the contract. At the option of the reporting person, the contract may be settled at maturity by delivering cash in lieu of stock. Promerica pledged 102,722 shares of the Issuer's common stock to secure its obligations under the contract and retains dividends and voting rights in the shares during the term of the pledge. The reporting person disclaims beneficial ownership of this stock except to the extent of his pecuniary interest. /s/ Lawrence J. Knopf, Attorney-in-fact 2009-01-06 -----END PRIVACY-ENHANCED MESSAGE-----